Owlet Inc. is a pioneering leader in the infant health technology sector, dedicated to enhancing newborn safety and wellness through innovative monitoring solutions. Its flagship product, the Owlet Smart Sock, employs advanced pulse oximetry to provide real-time insights into infants' heart rates and oxygen levels, directly connecting parents with critical health data via mobile devices. With a growing emphasis on pediatric health monitoring, Owlet is well-positioned to expand its product offerings and strengthen its presence in the evolving infant health market. The company's focus on actionable health information and improved pediatric care aligns with institutional investors' interest in cutting-edge health technology solutions.
| Revenue (TTM) | $107.06M |
| Gross Profit (TTM) | $54.45M |
| EBITDA | $-10.87M |
| Operating Margin | -24.40% |
| Return on Equity | -526.00% |
| Return on Assets | -10.00% |
| Revenue/Share (TTM) | $5.07 |
| Book Value | $0.71 |
| Price-to-Book | 7.30 |
| Price-to-Sales (TTM) | 1.57 |
| EV/Revenue | 1.532 |
| EV/EBITDA | -0.61 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 6.40% |
| Shares Outstanding | $29.00M |
| Float | $15.65M |
| % Insiders | 8.42% |
| % Institutions | 73.91% |